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he promyelocytic leukemia (PML) protein is aggre-
gated into nuclear bodies that are associated with
diverse nuclear processes. Here, we report that the
distance between a locus and its nearest PML body correlates
with the transcriptional activity and gene density around
the locus. Genes on the active X chromosome are more
signiﬁcantly associated with PML bodies than their silenced
homologues on the inactive X chromosome. We also found
that a histone-encoding gene cluster, which is transcribed
only in S-phase, is more strongly associated with PML bodies
T
 
in S-phase than in G0/G1 phase of the cell cycle. However,
visualization of speciﬁc RNA transcripts for several genes
showed that PML bodies were not themselves sites of tran-
scription for these genes. Furthermore, knock-down of PML
bodies by RNA interference did not preferentially change
the expression of genes closely associated with PML bodies.
We propose that PML bodies form in nuclear compartments
of high transcriptional activity, but they do not directly
regulate transcription of genes in these compartments.
 
Introduction
 
Our understanding of the structural and functional com-
partmentalization of the mammalian interphase nucleus has
been refined over the last few decades. It is now known
that the nucleus contains chromosome territories and
subnuclear domains that are involved in DNA replication,
transcription, and RNA processing (Cremer and Cremer,
2001). In each chromosome territory, genes are arranged
functionally, with certain active genes and clusters located
on the external surfaces (Dietzel et al., 1999; Volpi et al.,
2000). The positions of chromosome territories within the
nucleus appear to be related to gene density, with gene-rich
territories tending to be placed more centrally (Croft et al.,
1999). Analysis of individual loci within the nucleus has
revealed that certain silent genes associate with centromeric
heterochromatin in cycling lymphocytes (Brown et al.,
2001), whereas other genes associate with nuclear structures
such as SC-35 domains or coiled bodies (Frey and Matera,
1995; Smith et al., 1999).
One of the most prominent nuclear structures is the pro-
myelocytic leukemia (PML) nuclear body, also known as
PML oncogenic domain, nuclear domain 10, or Kremer
body. There are usually between 5 and 30 PML bodies per
nucleus, depending on the cell type and the stage of the cell
cycle (Koken et al., 1995). The PML protein, which is a major
and essential constituent of these bodies (Dyck et al., 1994;
Weis et al., 1994), is a member of a protein family character-
ized by an RBCC motif (consisting of RING finger, B-box,
and 
 
 
 
-helical coiled-coil domains; Jensen et al., 2001). This
motif allows the protein to interact with other proteins as
well as to homodimerize. In acute promyelocytic leukemia
(APL), the PML protein forms a fusion protein with retinoic
 
acid receptor-
 
 
 
, resulting in the redistribution of PML
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nuclear bodies into microspeckles (de The et al., 1991; God-
dard et al., 1991; Kakizuka et al., 1991).
PML bodies recruit a variety of other proteins, including
Sp100, SUMO-1, Daxx, pRB, p53, and BLM, suggesting
roles in DNA replication and repair, cell cycle control, and
apoptosis (Seeler and Dejean, 1999; Ruggero et al., 2000).
PML bodies are also implicated in gene transcription by
their recruitment of the histone acetyltransferase, cAMP-
response element binding protein (CBP), and RNA poly-
merase II (LaMorte et al., 1998; von Mikecz et al., 2000;
Boisvert et al., 2001), and the accumulation of nascent RNA
at their periphery (Boisvert et al., 2000). A role as a nuclear
depot, coordinating the accumulation and release of regula-
tory proteins in response to external stimuli, has also been
proposed (Negorev and Maul, 2001).
Using a novel statistical method, we recently showed that
PML bodies associate in primary human fibroblast nuclei
with the major histocompatibility complex (MHC), a gene-
rich region of chromosome 6 (Shiels et al., 2001). The clos-
est association was with the MHC class II region, which in-
cludes the transporter associated with antigen processing/
large multifunctional protease (TAP/LMP) locus containing
the 
 
LMP2/PSMB9
 
, 
 
LMP7/PSMB8
 
, 
 
TAP1
 
, and 
 
TAP2
 
 genes
involved in MHC class I antigen presentation. In contrast,
the gene-poor 6p24 region and the chromosome 6 cen-
tromere showed no association with PML bodies. These
data showed for the first time that PML bodies associate
with a specific genomic region. We have now extended this
analysis to multiple gene-rich and gene-poor regions on
other chromosomes in order to determine whether there is a
spatial organization of PML bodies relative to particular re-
gions of the genome. We find a significant correlation be-
tween association of PML bodies with genomic regions and
the transcriptional activity and gene density within these re-
gions. However, we also find that PML bodies do not serve
as obligate transcription sites for associated genes tested, nor
are basal transcription levels of these genes altered by knock-
down of PML protein.
 
Results
 
Measurement of locus–PML spatial proximity
 
We examined associations of PML bodies with loci from
chromosomes 1, 6, 7, 9, 14, 16, 17, 18, and 19 in compari-
son with the TAP/LMP locus in the MHC class II region
(Fig. 1; Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200305142/DC1). The TAP/LMP locus was
chosen as a reference, as we previously found that it was closely
associated with PML bodies (Shiels et al., 2001). For each
locus, three scores of association were made: the percentage
Figure 1. Mapped locations of loci analyzed for association with PML bodies. Loci found to be more significantly associated with PML bodies 
than the TAP/LMP locus are shown in red. Loci that are as associated as the TAP/LMP locus are shown in green. Loci that are less significantly 
associated are shown in black. For the X chromosome, loci on the active and inactive homologues were compared. Loci that were more 
significantly associated with PML bodies on the active than the inactive chromosome are shown in orange. Loci that are equally associated 
with PML bodies on both X chromosomes are shown in blue. 
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of loci in contact with a PML body, the percentage of loci
within 1 mm of the nearest PML body, and the mean mini-
mum distance (mmd) of the loci to the nearest PML body
(the last score was used for a statistical comparison with the
TAP/LMP locus using paired 
 
t
 
 tests). As expected, and in
agreement with others (Roix et al., 2003), we found that all
three scores correlated closely with each other (Fig. S1).
However, we also found that the differences in mmd associ-
ation of each locus with PML bodies persisted after scores
for alleles which were in direct contact with PML bodies
were removed from the dataset (Fig. S1). This implies either
that the association of loci with PML bodies does not re-
quire direct contact, or that loci that are statistically closer
have a higher chance of contact of a PML body due to their
dynamic nature (Chubb et al., 2002). We also found that all
centromeres, with the exception of the chromosome 9 cen-
tromere, were among the least associated with PML bodies,
using mmd measurements. However, due to the large FISH
signals of centromeres within the nucleus, a high proportion
of signals from centromeres are in contact with PML bodies.
Therefore, we propose that statistical measurements based
on distances, corrected for PML–PML distances, are less
prone to artifact than visual counting. Similar distance mea-
surements to measure proximity have also been used by oth-
ers (Roix et al., 2003).
 
PML bodies associate with regions of high 
transcriptional activity
 
Our initial observations suggested that regions of increased
transcriptional activity were more likely to be closely associ-
ated with PML bodies. Results for chromosomes 1 and 9,
each of which has regions of different gene densities and
transcriptional activity, are shown in Fig. 2 as examples of
our findings. Therefore, we analyzed the correlation statisti-
cally, using linear regression of the mean minimum locus–
PML distances (mmd-locus) for 54 loci shown in Table S1
against their local transcriptional activity. For analysis of lo-
cal transcriptional activity, expression levels were calculated
in arbitrary units for all known genes within 2 centiRays
around each locus using data from the human transcriptome
Figure 2. Comparison of locus–PML associations for genes on chromosomes 1 and 9 in relation to the local transcription activity, local 
gene density, and individual gene transcription. Local transcription activity was calculated for   1 centiRay around each locus, local gene 
density was calculated for   500 kb around each locus, and individual gene activity was determined relative to transcription of the  -actin 
gene. Locus–PML association is represented by mmd-locus in micrometers, with error bars showing 1 standard error. 
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map (Caron et al., 2001). The findings are represented in
Fig. 3 A, and show a significant correlation between high lo-
cal transcriptional activity and association with PML bodies.
(R
 
2 
 
  
 
0.16, F 
 
  
 
9.69, P 
 
  
 
0.003). This significance per-
sisted after weighting according to the variances. Further-
more, the strength of the association was increased by delet-
ing the centromeric and outlying loci with 
 
 
 
500 U (TAP/
LMP, 
 
C4
 
, 
 
PSMB10
 
, 
 
GNB1
 
, and 
 
PRKCZ
 
), resulting in R
 
2 
 
 
 
0.38, F 
 
  
 
25.6, P 
 
  
 
0.00001 (Fig. 3 B).
As the transcriptional activity of a region is dependent on
both the local gene density and the transcriptional status
of each gene, we wished to determine the relative contribu-
tions of both factors to the association. Regression analysis
showed that there was no significant correlation between the
transcription level of an individual gene (assessed by RT-
PCR) and its association with PML bodies. The findings are
represented in Fig. 3 C (R
 
2
 
 
 
  
 
0.069, F 
 
  
 
3.86, P 
 
  
 
0.055).
Local gene density was calculated within 1 megabase (Mb)
of the gene tested (data from the National Cell Biology In-
stitute and the Sanger Institute). Regions of 1 Mb were cho-
sen, as it was found that genes separated by 500 kb can have
statistically different associations with PML bodies (Fig. S2
A). Regression analysis showed a significant association of
gene-rich regions with PML bodies compared with gene-
poor regions (R
 
2
 
 
 
  
 
0.096, F 
 
  
 
5.52, P 
 
  
 
0.02). The find-
ings are represented in Fig. 3 D.
Therefore, our results showed that PML bodies associate
with genomic regions of increased transcription, rather than
with individual genes with high transcription levels. Con-
versely, genes such as 
 
NOTCH1
 
 in regions of high activity,
although not being highly expressed themselves, can have
strong associations with PML bodies statistically. Within
these regions of high local activity, PML bodies may associ-
ate with different genes at different times, again suggesting
that the association of a region was not the effect of an indi-
vidual gene (Fig. S2 B). Fig. S3 shows the regression analyses
using loci in direct contact with PML bodies.
 
Association of PML bodies with loci on the active 
and inactive X chromosomes
 
The active and inactive X chromosome territories have been
shown to have similar volumes (Eils et al., 1996). When we
Figure 3. Linear regression graphs comparing locus–PML association with different parameters. A and B show the the local transcriptional 
activity, C shows individual gene transcription, and D shows the local gene density. For B, centromeric and outlying loci were excluded. 
The locus–PML association is represented by mmd-locus in micrometers. The local transcription activity, local gene density, and individual 
gene transcription are calculated as in Fig. 2. Each bullet represents a locus. Each graph displays the best line fit for the regression. 
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compared the PML bodies around the active and inactive X
chromosomes in a female fibroblast cell line, we found more
PML bodies aggregating around the active X chromosome.
This was confirmed using the paired 
 
t
 
 test (mean number of
PML bodies around active X chromosome 
 
 
 
 1.34, inactive
X chromosome 
 
 
 
 0.78, P 
 
 
 
 0.0001; 
 
n
 
 
 
 
 
 51).
Specific loci along the active and inactive X chromo-
somes were then analyzed (Fig. 4). The homologues of six
of eleven loci studied (
 
G6PD
 
, 
 
GLA
 
, 
 
LAMP2
 
, 
 
UBE2A
 
,
 
NAP1L3
 
, and 
 
PSMD10
 
) on the active X chromosome were
found to be significantly more closely associated with PML
bodies (P 
 
 
 
 0.05) than those on the inactive X chromo-
some. In contrast, no significant difference was found in
association with PML bodies between the 
 
ALTE
 
, 
 
DMD
 
,
and 
 
USP9X
 
 loci in or around the pseudoautosomal regions
on Xp (Carrel et al., 1999), or with the centromeres on
these chromosomes. We also did not observe a more inte-
rior nuclear position of the Xp arm or the pseudoautoso-
mal loci compared with the Xq arm or nonpseudoautoso-
mal loci. Finally, the 
 
XIST
 
 genes on each X chromosome
associated with PML bodies to a similar extent. The 
 
XIST
 
gene, although only expressed from the inactive X chromo-
some (Brown et al., 1991), lies in a region not known to be
a pseudoautosomal region on the Xq arm.
Figure 4. Association of PML bodies 
with loci on the active and inactive X 
chromosomes. (A) WI-38 fibroblast cell 
nucleus showing the PSMD10 gene 
(green) on the X chromosome, PML 
bodies (blue), and propidium iodide 
counterstain (red). The inactive copy 
of the gene is distinguished by the Barr 
body (arrow). Bar, 5  m. (B) Comparison 
of the locus–PML distances for loci along 
active and inactive X chromosomes. 
The locus–PML association is represented 
as the mmd-locus distances for the active 
and inactive copy of each locus, with 
error bars showing 1 standard error. 
Results for loci in and out of the pseudo-
autosomal regions are pooled and 
displayed at the top and bottom of the 
figure, respectively.
Figure 5. Association of PML bodies 
with loci along chromosome 6, in cells 
in S-phase compared with cells in G0/
G1 phase. (A and B) MRC5 cell nuclei 
showing the histone gene cluster (red) 
at 6p22, PML bodies (blue), and incor-
porated BrdU (green) [A, cell in non-S 
(G0/G1) phase; B, cell in S-phase]. 
Bar, 5  m. (C) Locus–PML distances for 
different loci were compared between 
cells in S-phase versus G0/G1 phase. 
“(mmd-locus)   (mmd-PML)” on the x 
axis represents the distance to which a 
locus is further from or closer to the 
nearest PML body compared with the 
PML–PML distance, with error bars 
showing 1.4 standard errors. t tests were 
performed between the cells of G0/G1 
and S-phases for the four loci. Only the 
histone cluster on 6p22 shows a signifi-
cant difference in gene-PML association 
between cells in S- versus G0/G1 phase. 
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PML bodies have dynamic associations with 
cell cycle–regulated genes
 
Previously, we showed that association of the TAP/LMP
locus with PML bodies remains the same in the G0/G1 and
S-phases of the cell cycle (Shiels et al., 2001). We have now ex-
tended these analyses to other regions of chromosome 6. These
include the 6p22 region that contains genes encoding histone
proteins, a large proportion of which are transcribed at high
levels predominantly in S-phase (van der Meijden et al., 2002),
as well as the chromosome 6 centromere and 6p24 region.
Cells in G0/G1 and S-phases were distinguished by incor-
poration of BrdU (Fig. 5, A and B). Cells in G2 detected by
a double signal per allele were excluded. We found that cells
in S-phase had more PML bodies, and hence a decrease in
the PML–PML distances. Adjusting for this, no significant
difference was found between these phases of the cell cycle
for associations of PML bodies with the TAP/LMP, chro-
mosome 6 centromere, and 6p24 loci. In contrast, the 6p22
region showed a significant increase in association in S-phase
compared with G0/G1 phase (Fig. 5 C).
 
Proximity of a locus to PML bodies does not directly 
affect the transcription rate
 
Our work suggests that PML bodies associate with genomic
regions that have high transcription, rather than with highly
transcribed individual genes. To determine if PML bodies
are directly involved in the transcription of the genes within
these regions, we used RNA interference (RNAi) treatment
on MRC5 cells, with small-interfering RNA (siRNA) as pre-
viously designed (Bruno et al., 2003). Using immunofluo-
rescence, RNAi treatment resulted in 52% of cells expressing
no PML bodies, with the remainder expressing approxi-
mately half the normal number of PML bodies (Fig. 6, A
and B). With immunoblotting assays, we found the level of
PML protein to be reduced by 60% (Fig. 6 C). We would
expect this reduction of PML to lead to impaired transcrip-
tion of genes that are normally closely associated with PML
bodies. Semi-quantitative reverse-transcriptase PCR (RT-
PCR) was initially performed for all genes in Table S1 on
RNAi-treated cells compared with untreated and nonsilenc-
ing siRNA-treated cells. We found that the transcription lev-
els of genes that are normally closely associated with PML
bodies were not more substantially affected than those of
genes that are less closely associated with PML bodies (Fig.
S4 A). This measurement was confirmed using real-time
PCR on 12 genes chosen to represent the different levels of
association with PML bodies (Fig. 6 D).
Previous papers showed that treatment of NB4 APL cells
with all-trans retinoic acid (ATRA) results in the formation
of discrete PML bodies, as well as a change in expression of
Figure 6. The effect of knock-down and formation of new PML bodies on transcription levels. (A and B) MRC5 cells showing typical PML 
body distribution in normal (A) and PML siRNA-treated (B) cells. (C) Immunoblot assay for PML and  -actin (ACTB) proteins from cell lysates 
in PML RNAi-treated MRC5 cells (a), nonsilencing RNAi-treated cells (b), and untreated cells (c). The PML protein in sample a was quantified 
by analysis software to be 40% of the intensity compared with sample b, and 55% compared with sample c. The  -actin protein in sample a 
was 97% compared with sample b, and 98% compared with sample c. (D) Graph showing the change in transcription levels of genes in cells 
treated with PML RNAi, measured by real-time PCR, as compared with cells treated with nonsilencing siRNA. Loci studied were arranged in 
increasing mmd-locus values. The vertical axis represents the ratio of transcription level of a gene in RNAi-treated cells to that of the control 
group (  1), on a log2 scale. Therefore, a change above the line means an increase in expression of a gene, whereas a change below the line 
means a decrease in expression, compared with the control group. (E and F) NB4 cells showing the microspeckled pattern of PML protein 
(red) before ATRA treatment (E), and the formation of PML bodies (blue) after differentiation (F). F also shows four TAP/LMP loci (green) and 
6p24 loci (red) in the treated cells (NB4 cells have a hypotetraploid karyotype). (G) A graph showing the change in transcription levels by 
real-time PCR of genes in NB4 cells after treatment with ATRA, compared with untreated cells. Horizontal and vertical axes are scaled as in 
D. Bars, 5  m. 
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multiple genes (Lee et al., 2002; Fig. 6, E and F). In our
work, although more alterations in transcription levels were
noted, we again found no differences between genes that are
more closely associated with PML bodies and genes that are
less closely associated (Fig. S4 B). Once again, real-time
PCR analysis of a subset of these genes confirmed the initial
results (Fig. 6 G). An inverse correlation was not observed
between the effects of RNAi knock-down in MRC5 cells
and ATRA treatment of NB4 cells, presumably due to the
more complex changes in NB4 cells (Fig. S4 C).
However, we found that when NB4 cells were treated
with ATRA, newly formed PML bodies were positioned sta-
tistically closer to the TAP/LMP locus than the 6p24 locus
or the chromosome 6 centromere (mmd-TAP/LMP 
 
  
 
1.88
 
 
 
m vs. mmd-6p24 
 
  
 
2.41 
 
 
 
m, 
 
t
 
 score 
 
  
 
7.04, P 
 
  
 
0.01;
mmd-TAP/LMP 
 
  
 
1.92 
 
 
 
m vs. mmd-6cen 
 
  
 
2.65 
 
 
 
m, 
 
t
 
score 
 
  
 
8.18, P 
 
  
 
0.01). These experiments clearly show
that PML bodies form preferentially in specific nuclear re-
gions, in both ATRA-treated NB4 cells and fibroblasts.
They also suggest that PML bodies form in the vicinity of
(and in response to) local transcriptional activity, rather than
being responsible for nearby activity.
 
PML bodies are not invariably sites of transcription
 
To determine whether PML bodies are themselves sites of
transcription, we used RNA-FISH to visualize RNA tran-
scripts for three loci: the TAP/LMP cluster (in which the co-
ordinately expressed 
 
LMP2
 
, 
 
LMP7
 
, 
 
TAP1
 
, and 
 
TAP2
 
 were
simultaneously detected), and the 
 
HSPA5
 
 and 
 
COL1A1
 
genes (Fig. 7, A–C). To induce the expression and facilitate
RNA-FISH, cells were either treated with IFN
 
  at 200 U/ml
for detecting the TAP/LMP transcripts, or subjected to heat
shock for the HSPA5 transcript. These genes were selected
as they were among the most highly expressed in this paper
after induction. We found that although the majority of
RNA transcripts were adjacent to PML bodies, some tran-
scripts were some distance away (Fig. 7 D). These findings
suggest that neither PML bodies nor their immediate sur-
roundings serve specifically as transcription foci, at least for
these three loci.
PML bodies associate with genes encoding proteins 
of diverse functions
Because the MHC contains a large number of genes in-
volved in immune function and proteolysis, and there are
several paralogous regions scattered around the genome, we
wished to determine whether there is a preferential associa-
tion of these types of genes with PML bodies. First, we rean-
alyzed the proteasome encoding genes on chromosomes 1, 9,
14, and 16. We found that PSMB2 and PSMB4 genes are
statistically less associated using t test than the TAP/LMP lo-
cus (containing LMP2 and LMP7), whereas the other pro-
teasome-encoding genes tested were comparable with the
TAP/LMP locus (Table S1). Simultaneous visualization of
the TAP/LMP, PSMB7, and PSMB10 loci showed that
these loci do not preferentially associate with the same PML
body (Fig. S5 A). Some of the proteasome-encoding genes
(PSMB5, PSMB7, PSMB10, LMP2, LMP7, and PSME1/2)
were noted to be IFN responsive. We examined the effect of
200 U/ml IFN  on the TAP/LMP, PSMB7, and PSMB10
loci using the chromosome 6 centromere and a region on
band 6p24 as controls, and found that none of the regions
showed increased associations with PML bodies with IFN 
treatment (Table S2).
A second subset of genes examined were those paralogous
to genes in the MHC. Of these, HMG17 (1p36), ABC2,
Figure 7. Association of RNA-FISH signals with 
PML bodies for the TAP/LMP, HSPA5, and COL1A1 
loci. (A–C) MRC5 cells showing the RNA transcript 
signals (green), corresponding genomic loci (red), 
and PML bodies (blue) for the TAP/LMP (A), HSPA5 
(B), and COL1A1 (C) loci. The TAP/LMP locus 
comprises the genes LMP2, LMP7, TAP1, and 
TAP2. (D) The proportion of RNA signals (in cells 
with detectable signals) that were in direct contact 
with a PML body for the three loci, compared with 
those not in direct contact. RNA signals tended 
to be larger than the corresponding DNA signals, 
suggesting the spreading of RNA transcripts from 
the gene location. RNA loci were considered in 
contact with a PML body if any part of the detect-
able signal was visually seen to be in contact. The 
percentages of RNA signals in contact with PML 
bodies were 68% (TAP/LMP), 68% (HSPA5), and 
65% (COL1A1). For the same loci (with detectable 
RNA signals), the percentages of DNA signals in 
contact with PML bodies (which may reflect the 
site of transcription; not depicted) were 52% 
(TMP/LMP), 70% (HSPA5), and 39% (COL1A1). 
These scores were not directly comparable to the 
corresponding scores in Table S1 (available at 
http://www.jcb.org/cgi/content/full/jcb.200305142/
DC1) because for TAP/LMP and HSPA5, cells were 
treated such that the number of PML bodies were 
increased. Bars, 5  m.522 The Journal of Cell Biology | Volume 164, Number 4, 2004
and the adjacent NOTCH1 genes (9q34) were statistically
more associated with PML bodies than the TAP/LMP locus,
and were the most highly associated of all genes tested (Fig.
S5 B). The NOTCH2 gene (1p11-13) was statistically as as-
sociated as the TAP/LMP locus, whereas the CD1 (1q21)
and HSPA6 (1q12-21) genes were not associated.
Next, we examined a set of genes encoding structural pro-
teins that had been tested elsewhere for association with SC-
35 domains (Smith et al., 1999). The COL1A1, LMNA, and
ACTB genes were reported to be associated with SC-35 do-
mains, whereas LAMB1 was not. These findings were verified
by our experiments (unpublished data). As PML bodies and
SC-35 domains both lie in the interchromosomal space, the
apparent association of a locus with a PML body may actually
reflect its association with an SC-35 domain. Thus, we exam-
ined the association of these four genes with PML bodies, and
found that although the COL1A1, LMNA, and LAMB1 genes
associate with PML bodies to the same extent as the TAP/
LMP locus, the ACTB gene was less significantly associated.
We also studied these four loci, as well as the TAP/LMP lo-
cus, the chromosome 6 centromere, and the 6p24 region,
with PML bodies and SC-35 domains labeled simultaneously,
and found that these loci may be in contact with either PML
bodies or SC-35 domains independently (Fig. S5 C).
These data suggest that PML bodies do not associate uni-
formly with particular sets of functionally related genes, nor
are they limited in their association with only a single subset
of genes. Furthermore, their association with certain geno-
mic regions is unrelated to the proximity of these regions to
SC-35 domains.
Discussion
The precise roles of PML bodies have remained elusive de-
spite intensive research. In this work, we formally tested the
hypothesis that PML bodies are located close to certain ge-
nomic regions and tested their function in transcriptional
activity. By examining multiple genomic regions with differ-
ent features, we found that PML bodies associate with geno-
mic regions of high transcriptional activity, which is a func-
tion of both the gene density and the proportion of genes
that are active. Single genes that are highly expressed do not
alone show significant associations with PML bodies. The
regression model showed that some loci were found outside
the line fit, suggesting other factors may play a role in their
association with PML bodies. For example, the chromosome
9 centromere showed a strong statistical association with
PML bodies, possibly due to a region of high gene density
and transcriptional activity located adjacent to the cen-
tromere on band 9p13. Alternatively, the heterochromatin
in this centromere has been shown to have unique properties
(Jolly et al., 2002). The organization of PML bodies in rela-
tion to transcriptionally active regions is further supported
by the association of PML bodies with many genes on the
active X chromosome compared with their homologues on
the inactive X chromosome, and with replication-dependent
histone genes on chromosome 6 in S-phase cells compared
with those in G0/G1 phase cells. Newly formed PML bodies
in NB4 cells after ATRA treatment also showed a preference
for the TAP/LMP region compared with other loci along
chromosome 6. Together, these findings show that PML
bodies lie within or in close proximity to transcriptionally
permissive nuclear compartments (Isogai and Tjian, 2003).
PML bodies have been linked with transcription in several
reports. For example, RNA polymerase II transcription foci,
visualized by fluorouridine, and nascent RNA have been ob-
served in and around PML bodies (LaMorte et al., 1998;
Boisvert et al., 2000; von Mikecz et al., 2000). PML bodies
also recruit CBP, a transcriptional coactivator with histone
acetylase activity (LaMorte et al., 1998; von Mikecz et al.,
2000; Boisvert et al., 2001). However, PML bodies do not
appear to be involved with all sites of transcriptional activity
because only a minor proportion of transcription foci and
regions of acetylated histones in the nucleus colocalize with
PML bodies (Boisvert et al., 2000; Kiesslich et al., 2002).
In our experiments, certain loci were found to be associ-
ated more statistically with PML bodies, but this association
was retained even when those loci that touch PML bodies
are excluded from the calculations. This result may be ex-
plained by the fact that chromatin can move up to 2 mm
(Chubb et al., 2002), and genes that are statistically closer
might therefore associate intermittently with PML bodies
more often. However, our RNA-FISH experiments with the
loci TAP/LMP, HSPA5, and COL1A1 showed that these
genes when being transcribed, or their transcripts, are not al-
ways adjacent or touching PML bodies, although the three
loci themselves showed a high degree of association with
PML bodies. This is similar to a previous report in which
Cajal bodies associated with histone genes, but were not nec-
essarily sites for transcription (Shopland et al., 2001). There-
fore, we propose that a locus may form a statistically signifi-
cant but indirect association with PML bodies as a result of
its location within a nuclear compartment in which a PML
body is likewise positioned.
The four genes in the TAP/LMP cluster are particularly in-
teresting in this regard because they encode proteins that play
a central role in the presentation of MHC class I molecules at
the cell surface (van Endert, 1999). Expression of these genes
was reported to be up-regulated after transfection of PML
protein into mouse tumor cells with defective antigen presen-
tation (Zheng et al., 1998). In our experiments using a hu-
man cell line, we found that PML bodies are not themselves
sites of transcription for these genes, and that PML knock-
down by RNAi does not diminish transcription of these
genes. We have not yet explored the possibility that PML
bodies are involved in post-transcriptional events, as pro-
posed by others (Borden, 2002). However, in human cells, it
has recently been shown that PML is not directly involved in
the regulation of MHC class I antigen expression at the cell
surface (Bruno et al., 2003), complementing our transcrip-
tion analysis of the HLA-A and TAP/LMP genes.
These results also prompted us to examine whether PML
bodies are associated with functional subsets of genes. Genes
with immune function were of immediate interest in view of
our previous demonstration of a spatial association between
the MHC and PML bodies (Shiels et al., 2001), and other
evidence linking PML bodies to immune function. For ex-
ample, IFN  treatment leads to increased expression of the
PML gene and an increase in the number of PML bodies
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of nuclear DNA helicase II, nascent RNA transcripts, and
CBP associating with PML bodies (Fuchsova et al., 2002;
Kiesslich et al., 2002).
In our current experiments, significant associations with
PML bodies were seen with many genes that have immune
function and/or are IFN responsive. These include genes en-
coding the proteasome subunits LMP2, LMP7, PSMB10,
PSME1, and PSME2, which are up-regulated by IFN , and
the PSMB7, COL1A1, and LMNA genes, which are down-
regulated by IFN  (Boehm et al., 1997). Although these
findings might suggest that PML bodies play a role in the
transcription of such genes, no increased association of sev-
eral of the IFN up-regulated genes with PML bodies was ob-
served after IFN  treatment. It should be noted that our sta-
tistical method takes into account the increase in the
number of PML bodies in the nucleus, which is particularly
important when assessing the effects of treatments that in-
crease the number of PML bodies.
Many of the immune-related genes we tested lie in gene-
rich regions and may be clustered to facilitate coordinated ex-
pression. Therefore, using our current statistical model, it is
not possible to determine whether the association is due to the
presence of functionally related genes rather than other factors
such as gene density. It should also be noted that genes with
nonimmune functions such as HMG17 (coding a chromo-
somal protein), ABC2 (transporter protein), and NOTCH1
(signaling receptor) show the most highly significant associa-
tions of all genes tested with PML bodies (Luciani et al.,
1994; Artavanis-Tsakonas et al., 1995; Bustin et al., 1995).
Thus, these data demonstrate that although PML bodies asso-
ciate with a large group of immune-related genes, they are also
strongly associated with other genes with disparate functions.
The central question to arise from these findings is
whether PML bodies directly regulate transcription of genes
with which they are spatially associated. Our RNAi experi-
ments showed that knock-down of PML protein, leading to
a reduction in the number of PML bodies, did not preferen-
tially alter transcription levels of genes that were closer to
PML bodies, or other subsets of genes such as those which
are IFN responsive, mentioned earlier in this section. Regu-
lation of transcription of specific genes by PML bodies has
been previously reported to occur by the accumulation and
release of transcriptional activators and repressors in a con-
trolled manner (Vallian et al., 1998; Guo et al., 2000; Le-
hembre et al., 2001; Wu et al., 2002). However, these re-
ports are not directly comparable to ours because they use
transfection of exogenous PML protein and various tran-
scription factors. Furthermore, they show that PML facili-
tates, but is not essential for, specific transcription pathways.
Therefore, the role of PML bodies in transcription in the
physiological setting has not been established. It may be that
PML bodies only regulate transcription during overexpres-
sion or activation of a particular pathway, rather than basal
transcription. Alternatively, the association of a genomic re-
gion with PML bodies may influence the expression of
nearby genes that were not analyzed here by RT-PCR.
Previously, we showed that giant chromatin loops carrying
the MHC region appear after IFN induction of MHC gene
expression (Volpi et al., 2000). We now find that the posi-
tioning of signals at the painted chromosome territory surface
or on large external chromatin loops does not correlate with
increased PML association (Fig. S4, Table S3), despite PML
bodies being found mostly in the interchromosomal space
(Bridger et al., 1998). This result concurs with that of others
(Williams et al., 2002). However, we noted that loci that had
a higher incidence of external signals were also more likely to
associate with PML bodies, although not necessarily at the
same time. Both observations may be independently related
to the transcriptional activity, as it has been shown that local
gene density and transcriptional activity also affect the exter-
nal localization of loci (Mahy et al., 2002). We excluded the
possibility that the observed association of loci with PML
bodies was due to their proximity to other nuclear inclusions
such as Cajal bodies (Shiels et al., 2001) or SC-35 domains.
It may be argued that PML bodies associate with specific loci
due to their radial position in the interior of the cell nucleus.
Our data on the pseudoautosomal region of the inactive X
chromosome appear to suggest otherwise.
A role for PML bodies in transcription through the regu-
lated recruitment and release of factors necessary for tran-
scription has been mentioned above. A more general role for
PML bodies as a nuclear depot containing transcription fac-
tors and other proteins that alter the nuclear activities in re-
sponse to external stimuli, such as stress, has recently been
proposed (Negorev and Maul, 2001). The recent discovery
that proteasomes can accumulate in PML bodies suggests
that degradation of excess proteins may occur at these sites as
well (Mattson, 2000; Fabunmi et al., 2001). Therefore, we
suggest that PML bodies are distributed so they function as
depots for factors required for dense transcription foci in
these regions, as shown in Fig. 8.
Further, we propose that this positioning of PML bodies is
more predominant under normal cell growth. In specific cir-
cumstances, a proportion of PML bodies are also found ag-
Figure 8. Proposed model of PML body function and position in 
the nucleus. PML bodies aggregate at regions of highest density/levels 
of transcription activity. Transcribed genes that are in regions 
with low overall transcription activity are less likely to associate 
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gregated at specific locations, such as at sites of stable trans-
fected lac operator arrays after activation by the lac repressor
protein (Tsukamoto et al., 2000). At sites of DNA damage,
the BLM and MRE11 DNA repair proteins are recruited to
the aggregated PML bodies (Bischof et al., 2001; Muto et al.,
2001; Carbone et al., 2002). With these heterogeneous func-
tions, individual PML bodies within a nucleus may have dif-
ferent constituent proteins and perform different functions,
depending on the requirements of the nucleus (Bloch et al.,
1999). However, we conclude that in interphase cells, PML
bodies are distributed in a specific manner in proximity to
nuclear domains of high transcriptional activity.
Materials and methods
Cell culture and treatment
MRC5 male and WI-38 female human primary fibroblasts were obtained
from the American Type Culture Collection, and were cultured as mono-
layers in RPMI 1640 media supplemented with 10% FCS and 2 mM gluta-
mine. NB4 (APL) cells were grown in suspension in the same medium.
Heat shock of MRC5 cells was performed at 44 C for 1 h on a heating
block. Recombinant human IFN  (R&D Systems) was used at a concentra-
tion of 200 U/ml for 24 h to up-regulate transcription of MHC genes. Cells
in S-phase were labeled by adding BrdU (Sigma-Aldrich) to the culture me-
dium at a final concentration of 100  M for 1 h immediately before fixa-
tion. Differentiation of NB4 cells was induced with 1  M ATRA for 48 h.
RNAi treatment on MRC5 cells was performed using 21-nt siRNA strands
as described previously (Bruno et al., 2003). This oligonucleotide and a
nonsilencing control siRNA oligonucleotide were obtained from QIAGEN.
Transfection of siRNAs was performed using the TransMessenger™ reagent
(QIAGEN) or the Oligofectamine
® reagent (Invitrogen) 48–96 h before har-
vesting.
Antibodies and DNA probes
Antibodies used in this work were as follows: Rabbit polyclonal anti-PML
(Borden et al., 1995) to detect PML nuclear bodies, mouse anti-BrdUTP
(Boehringer) to detect BrdU incorporated into newly replicating DNA, and
monoclonal mouse anti-splicing factor SC-35 (Sigma-Aldrich) to detect SC-
35 domains. Secondary antibodies used were anti–mouse Alexa
® 488,
anti–rabbit Alexa
® 546 (both from Molecular Probes, Inc.), and anti–rabbit
cy5 (Amersham Biosciences).
The LMP/TAP locus in the MHC was detected using a pool of cosmids
(HA14, U15, U10, and M4) containing the LMP2, LMP7, TAP1, and TAP2
genes (a gift from S. Beck, Sanger Institute, Cambridge, UK). A subsection
of the 6p24 region was detected using pooled cosmids A9.5, B5.10,
B10.10, B12.10, E11.2, and F1.6 (a gift from J. Ragoussis, University of
Oxford, Oxford, UK). The histone H2-4 region in band 6p22 was detected
using pooled cosmids A1037, H2317, and N1948 (a gift from J. Trowsdale,
University of Cambridge, Cambridge, UK). Probes for loci on other chro-
mosomes were bacterial artificial chromosomes and P1 artificial chromo-
somes derived from Dr. Pieter de Jong (Roswell Park Cancer Institute, Buf-
falo, NY) and provided by the Sanger Institute (listed in Table S4). The
centromeres and whole-chromosome territories of chromosomes 1, 6, 9,
18 and 19, and X were detected using commercial biotinylated satellite
probes and red or green whole-chromosome paints (Appligene Oncor). Xp
and Xq arm probes (biotin and digoxigenin labeled, respectively) were ob-
tained from Cambio. Because the satellite probe for chromosome 19 cross-
hybridizes to chromosomes 1 and 6, it was hybridized together with the
chromosome 19 paint.
Combined immunofluorescence and FISH (immuno-FISH)
Cells were grown, fixed, and permeabilized as described previously (Shiels
et al., 2001). Cells were heat denatured on slides before hybridization of
300 ng denatured and biotin- and/or digoxigenin-labeled DNA probe at
37 C overnight, followed by standard formamide and SSC washes. DNA
probes used are described in the previous section. Biotin-labeled DNA
probes were detected using streptavidin-Alexa
® 546 (Molecular Probes,
Inc.) or streptavidin-Cy5 (Cambio), and digoxigenin-labeled DNA probes
were detected using mouse and sheep mouse anti-digoxigenin-FITC or
-Texas red (Sigma-Aldrich and Boehringer). Detection of nuclear proteins
by immunofluorescence was performed simultaneously with the FISH de-
tection steps. Female diploid fibroblast cells (WI-38) were counterstained
in propidium iodide at 1 mg/ml. The inactive X chromosome was identi-
fied as a densely stained Barr body.
For RNA-FISH experiments, the biotinylated genomic probes for TAP/
LMP, HSPA5, and COL1A1 were chosen at higher amounts of 600 ng per
slide. Ribonuclease-free reagents were used where possible, and vanadyl
ribonucleoside complex (New England Biolabs, Inc.) was added to the per-
meabilization and hybridization steps at a final concentration of 20 mM.
The slide denaturation step was omitted, and detection of biotin was per-
formed using the tyramide signal amplification system (PerkinElmer). Cells
were then treated with ribonuclease A, heat denatured, and DNA-FISH
(using digoxigenin-labeled probes for the same gene loci) and immunoflu-
orescence were performed as above.
Microscopy and distance measurements
Image capture and analysis were as described previously (Shiels et al.,
2001). Confocal image stacks were processed using the Image3D program
(written by S.A. Islam). This produces three-dimensional coordinates of
centroid positions for each locus and PML body, allowing the Euclidean
distance between two foci to be calculated.
At least 30 nuclei were captured per experiment. For each locus, we cal-
culated the distance to its nearest PML body, referred to as the minimum lo-
cus–PML distance. The mean minimum locus–PML distance (mmd-locus)
for the two alleles was obtained for each nucleus, except for experiments
involving the active/inactive X genes and locus position within chromo-
some territories where each allele was considered separately. In addition,
for each PML body we calculated the minimum distance to its nearest PML
body. The mean of the minimum PML–PML distances (mmd-PML) for all
PML bodies was then calculated for each nucleus. Where three-color ex-
periments were used to compare directly mmd-locus for two loci, the val-
ues of mmd-locus1 and mmd-locus2 were obtained as above. The percent-
age of minimum locus–PML distances that were  1   m was also
calculated. In addition, each cell was examined as a three-dimensional
stack of images by two independent observers. Each locus was scored to be
either physically touching a PML body, or not. Percentage of loci in contact
with a PML body was calculated as the mean of the two observations.
Statistical analysis
To determine whether the associations of loci with PML bodies correlate
with their transcriptional state, the gene density, or the transcriptional ac-
tivity surrounding the loci, multiple linear regression analyses were per-
formed. Where appropriate, weighted least squares were used with
weights proportional to the inverse of the variance of the mmd-locus dis-
tance. Gene density was calculated for 500 kb on either side of the gene
tested, using mean data from the National Cell Biology Institute gene map-
ping database (http://www.ncbi.nlm.nih.gov/) and the Sanger Institute
(http://www.ensembl.org). Novel or predicted genes were included. The
transcriptional level of a gene was determined by RT-PCR (see next sec-
tion). Local transcriptional activity was calculated taking the expression
data from the human transcriptome map (http://bioinfo.amc.uva.nl/HTMseq/
controller). We summed the expression levels of genes within 1 centiRay
on either side of the gene tested or the nearest available neighboring gene
mapped, using the GB4 radiation hybrid map. As the MRC5 cell line is a fi-
broblast cell line derived from the lung, relative transcription units were
derived for each gene from the averages of data from the normal lung and
the skin fibroblast libraries. The distances (mmd-locus) for individual loci
were analyzed against all three variables. Higher R
2 and F indicated a
stronger correlation, with P score values of  0.05 being considered a sig-
nificant correlation.
For direct comparisons between the mmd for two loci, the t test was
performed using two-sided P values, assuming the null hypothesis of equal
means for the two loci. Where both loci were detected simultaneously us-
ing three-color experiments, paired t tests were used. For comparisons of
mmd-locus between two different sets of cells, such as in a set of untreated
cells versus treated cells, or cells in G0/G1 phase versus S-phase, the effect
of treatment was then investigated using an unpaired t test on the two sets
of mmd-locus values under the assumption of equal variance. Where the
mmd-PML distances are statistically different in the two sets of cells, the
comparison was made between the differences [(mmd-locus)   (mmd-
PML)]. The difference in the association of PML bodies between two loci is
said to be statistically significant if the P value is  0.05.
Total RNA isolation, RT-PCR, and real-time PCR
RNA was extracted from cells using TRIzol
® reagent (GIBCO BRL) accord-
ing to the manufacturer’s protocol. 1  g total RNA was then reverse tran-
scribed using the First Strand cDNA Synthesis kit (Amersham Biosciences),
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with 1  M of each primer (see Table S5), and the appropriate volumes of
the Taq PCR Master Mix (QIAGEN) and distilled water. The PCR reaction
was performed for 30 cycles. PCR products were loaded onto 1.5% aga-
rose gels labeled with ethidium bromide. The PCR product bands were
scanned using UV light with LabWorks capture software (Ultra-Violet
Products), which allowed the intensity of the bands to be quantified. Rela-
tive intensities were calculated using the intensity of the expressed gene
 -actin (ACTB) as the reference (  1). To compare expression in different
cell populations (e.g., after RNAi or ATRA treatments), band intensities
were first normalized on the ACTB gene for the corresponding cDNA sam-
ple. The relative intensities for the treated group and the control group
were then calculated.
For real-time PCR, cDNA samples were prepared as above. Primers
were redesigned (Table S5), and 300 nM of each primer pair was mixed
with cDNA from 100 ng total RNA and the appropriate volumes of SYBR
®
green PCR Master Mix (Applied Biosystems) and distilled water. The PCR
reaction was performed on a Sequence Detector System (ABI PRISM 7700;
Applied Biosystems) for 40 cycles, with an annealing temperature of 60 C.
Averages of calculated thresholds (Cts) were obtained for duplicated sam-
ples, and corrected against the ACTB reference. The difference in Cts be-
tween treated and control samples then allowed the relative expression
of a gene to be quantitated as follows: ratio of treated to untreated  
2
 [ (Ct-treated   Ct-ACTB)   (Ct-control   Ct-ACTB) ].
Protein electrophoresis and immunoblotting
Whole-cell lysates were obtained by adding 1 cell volume of 2  electro-
phoresis sample buffer (125 mM Tris, pH 6.8, 4% SDS, 10% glycerol,
0.006% bromophenol blue, and 2% DTT) to MRC5 cells treated with
RNAi and controls. The lysate was boiled further for 5 min, and equal vol-
umes were separated on 4–20% SDS-PAGE gels. Proteins were transferred
to nitrocellulose, and PML and  -actin protein bands were detected with
mouse monoclonals anti-PML (PG-M3; Santa Cruz Biotechnology, Inc.)
and anti- -actin (Sigma-Aldrich) antibodies, using a WesternBreeze kit (In-
vitrogen). Protein bands were quantitated using LabWorks software (Ultra-
Violet Products).
Online supplemental material
Fig. S1 shows the relationship between loci–PML distance measurements
and visual counts of loci in direct contact with PML bodies. Fig. S2 is rep-
resentative of cells from immuno-FISH experiments used to detect two loci
mapped in close proximity to each other, and their association with PML
bodies. Fig. S3 correlates the proportion of genes in direct contact with
PML bodies, with their local transcriptional activity, gene density, and in-
dividual gene transcription levels. Fig. S4 shows the effect of knock-down
and formation of new PML bodies on the transcription levels of all genes
analyzed by RT-PCR. Fig. S5 represents cells from immuno-FISH experi-
ments in which PML bodies and loci from subsets of similar genes are de-
tected. Fig. S6 illustrates the relationship between locus–PML associations
and the position of loci within their chromosome territories.
Table S1 shows the detailed results of the locus–PML association for all
autosomal loci analyzed, together with their local transcriptional activity,
gene density, and individual gene transcription levels. Table S2 shows the
effect of IFN  on the associations of various loci along chromosome 6 with
PML bodies. Table S3 compares the direct contact of loci and PML bodies
with the location of the locus signals relative to the chromosome terri-
tory. Table S4 lists the bacterial/P-1 artificial chromosome probes used in
the immuno-FISH experiments and the primers used in RT-PCR. Table S5
lists the primers used for genes analyzed using real-time PCR. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200305142/DC1.
We thank Stephan Beck, Jiannis Ragoussis, and John Trowsdale for geno-
mic probes. We also thank Ian Tomlinson, Alistair Newall, Petros Takou-
sis, and Emanuel Volpi for helpful discussions.
This work was supported by Cancer Research UK.
Submitted: 29 May 2003
Accepted: 6 January 2004
References
Artavanis-Tsakonas, S., K. Matsuno, and M.E. Fortini. 1995. Notch signaling. Sci-
ence. 268:225–232.
Bischof, O., S.H. Kim, J. Irving, S. Beresten, N.A. Ellis, and J. Campisi. 2001.
Regulation and localization of the Bloom syndrome protein in response to
DNA damage. J. Cell Biol. 153:367–380.
Bloch, D.B., J.D. Chiche, D. Orth, S.M. de la Monte, A. Rosenzweig, and K.D.
Bloch. 1999. Structural and functional heterogeneity of nuclear bodies. Mol.
Cell. Biol. 19:4423–4430.
Boehm, U., T. Klamp, M. Groot, and J.C. Howard. 1997. Cellular responses to
interferon- . Annu. Rev. Immunol. 15:749–795.
Boisvert, F.M., M.J. Hendzel, and D.P. Bazett-Jones. 2000. Promyelocytic leuke-
mia (PML) nuclear bodies are protein structures that do not accumulate
RNA. J. Cell Biol. 148:283–292.
Boisvert, F.M., M.J. Kruhlak, A.K. Box, M.J. Hendzel, and D.P. Bazett-Jones.
2001. The transcription coactivator CBP is a dynamic component of the
promyelocytic leukemia nuclear body. J. Cell Biol. 152:1099–1106.
Borden, K.L. 2002. Pondering the promyelocytic leukemia protein (PML) puzzle:
possible functions for PML nuclear bodies. Mol. Cell. Biol. 22:5259–5269.
Borden, K.L., M.N. Boddy, J. Lally, N.J. O’Reilly, S. Martin, K. Howe, E.
Solomon, and P.S. Freemont. 1995. The solution structure of the RING
finger domain from the acute promyelocytic leukaemia proto-oncoprotein
PML. EMBO J. 14:1532–1541.
Bridger, J.M., H. Herrmann, C. Munkel, and P. Lichter. 1998. Identification of an
interchromosomal compartment by polymerization of nuclear-targeted vi-
mentin. J. Cell Sci. 111:1241–1253.
Brown, C.J., A. Ballabio, J.L. Rupert, R.G. Lafreniere, M. Grompe, R. Tonlorenzi,
and H.F. Willard. 1991. A gene from the region of the human X inactiva-
tion centre is expressed exclusively from the inactive X chromosome. Nature.
349:38–44.
Brown, K.E., S. Amoils, J.M. Horn, V.J. Buckle, D.R. Higgs, M. Merkenschlager,
and A.G. Fisher. 2001. Expression of  - and  -globin genes occurs within
different nuclear domains in haemopoietic cells. Nat. Cell Biol. 3:602–606.
Bruno, S., F. Ghiotto, F. Fais, M. Fagioli, L. Luzi, P.G. Pelicci, C.E. Grossi, and E.
Ciccone. 2003. The PML gene is not involved in the regulation of MHC
class I expression in human cell lines. Blood. 101:3514–3519.
Bustin, M., L. Trieschmann, and Y.V. Postnikov. 1995. The HMG-14/-17 chro-
mosomal protein family: architectural elements that enhance transcription
from chromatin templates. Semin. Cell Biol. 6:247–255.
Carbone, R., M. Pearson, S. Minucci, and P.G. Pelicci. 2002. PML NBs associate
with the hMre11 complex and p53 at sites of irradiation induced DNA
damage. Oncogene. 21:1633–1640.
Caron, H., B. van Schaik, M. van der Mee, F. Baas, G. Riggins, P. van Sluis, M.C.
Hermus, R. van Asperen, K. Boon, P.A. Voute, et al. 2001. The human
transcriptome map: clustering of highly expressed genes in chromosomal do-
mains. Science. 291:1289–1292.
Carrel, L., A.A. Cottle, K.C. Goglin, and H.F. Willard. 1999. A first-generation
X-inactivation profile of the human X chromosome. Proc. Natl. Acad. Sci.
USA. 96:14440–14444.
Chubb, J.R., S. Boyle, P. Perry, and W.A. Bickmore. 2002. Chromatin motion is
constrained by association with nuclear compartments in human cells. Curr.
Biol. 12:439–445.
Cremer, T., and C. Cremer. 2001. Chromosome territories, nuclear architecture
and gene regulation in mammalian cells. Nat. Rev. Genet. 2:292–301.
Croft, J.A., J.M. Bridger, S. Boyle, P. Perry, P. Teague, and W.A. Bickmore. 1999.
Differences in the localization and morphology of chromosomes in the hu-
man nucleus. J. Cell Biol. 145:1119–1131.
de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991.
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation
in acute promyelocytic leukemia encodes a functionally altered RAR. Cell.
66:675–684.
Dietzel, S., K. Schiebel, G. Little, P. Edelmann, G.A. Rappold, R. Eils, C. Cremer,
and T. Cremer. 1999. The 3D positioning of ANT2 and ANT3 genes
within female X chromosome territories correlates with gene activity. Exp.
Cell Res. 252:363–375.
Dyck, J.A., G.G. Maul, W.H. Miller, Jr., J.D. Chen, A. Kakizuka, and R.M.
Evans. 1994. A novel macromolecular structure is a target of the promyelo-
cyte-retinoic acid receptor oncoprotein. Cell. 76:333–343.
Eils, R., S. Dietzel, E. Bertin, E. Schrock, M.R. Speicher, T. Ried, M. Robert-
Nicoud, C. Cremer, and T. Cremer. 1996. Three-dimensional reconstruc-
tion of painted human interphase chromosomes: active and inactive X chro-
mosome territories have similar volumes but differ in shape and surface
structure. J. Cell Biol. 135:1427–1440.
Fabunmi, R.P., W.C. Wigley, P.J. Thomas, and G.N. DeMartino. 2001. Inter-
feron   regulates accumulation of the proteasome activator PA28 and im-
munoproteasomes at nuclear PML bodies. J. Cell Sci. 114:29–36.526 The Journal of Cell Biology | Volume 164, Number 4, 2004
Frey, M.R., and A.G. Matera. 1995. Coiled bodies contain U7 small nuclear RNA
and associate with specific DNA sequences in interphase human cells. Proc.
Natl. Acad. Sci. USA. 92:5915–5919.
Fuchsova, B., P. Novak, J. Kafkova, and P. Hozak. 2002. Nuclear DNA helicase II
is recruited to IFN- -activated transcription sites at PML nuclear bodies. J.
Cell Biol. 158:463–473.
Goddard, A.D., J. Borrow, P.S. Freemont, and E. Solomon. 1991. Characteriza-
tion of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic
leukemia. Science. 254:1371–1374.
Guo, A., P. Salomoni, J. Luo, A. Shih, S. Zhong, W. Gu, and P. Paolo Pandolfi.
2000. The function of PML in p53-dependent apoptosis. Nat. Cell Biol.
2:730–736.
Isogai, Y., and R. Tjian. 2003. Targeting genes and transcription factors to segre-
gated nuclear compartments. Curr. Opin. Cell Biol. 15:296–303.
Jensen, K., C. Shiels, and P.S. Freemont. 2001. PML protein isoforms and the
RBCC/TRIM motif. Oncogene. 20:7223–7233.
Jolly, C., L. Konecny, D.L. Grady, Y.A. Kutskova, J.J. Cotto, R.I. Morimoto, and
C. Vourc’h. 2002. In vivo binding of active heat shock transcription factor 1
to human chromosome 9 heterochromatin during stress. J. Cell Biol. 156:
775–781.
Kakizuka, A., W.H. Miller, Jr., K. Umesono, R.P. Warrell, Jr., S.R. Frankel, V.V.
Murty, E. Dmitrovsky, and R.M. Evans. 1991. Chromosomal translocation
t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a
novel putative transcription factor, PML. Cell. 66:663–674.
Kiesslich, A., A. von Mikecz, and P. Hemmerich. 2002. Cell cycle-dependent asso-
ciation of PML bodies with sites of active transcription in nuclei of mamma-
lian cells. J. Struct. Biol. 140:167–179.
Koken, M.H., G. Linares-Cruz, F. Quignon, A. Viron, M.K. Chelbi-Alix, J. Sob-
czak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de The. 1995. The PML
growth-suppressor has an altered expression in human oncogenesis. Onco-
gene. 10:1315–1324.
LaMorte, V.J., J.A. Dyck, R.L. Ochs, and R.M. Evans. 1998. Localization of na-
scent RNA and CREB binding protein with the PML-containing nuclear
body. Proc. Natl. Acad. Sci. USA. 95:4991–4996.
Lee, K.H., M.Y. Chang, J.I. Ahn, D.H. Yu, S.S. Jung, J.H. Choi, Y.H. Noh, Y.S.
Lee, and M.J. Ahn. 2002. Differential gene expression in retinoic acid-
induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-
60 cells. Biochem. Biophys. Res. Commun. 296:1125–1133.
Lehembre, F., S. Muller, P.P. Pandolfi, and A. Dejean. 2001. Regulation of Pax3
transcriptional activity by SUMO-1-modified PML. Oncogene. 20:1–9.
Luciani, M.F., F. Denizot, S. Savary, M.G. Mattei, and G. Chimini. 1994. Clon-
ing of two novel ABC transporters mapping on human chromosome 9. Ge-
nomics. 21:150–159.
Mahy, N.L., P.E. Perry, S. Gilchrist, R.A. Baldock, and W.A. Bickmore. 2002.
Spatial organization of active and inactive genes and noncoding DNA
within chromosome territories. J. Cell Biol. 157:579–589.
Mattson, J.C. 2000. Acute promyelocytic leukemia. From morphology to molecu-
lar lesions. Clin. Lab. Med. 20:83–103.
Muto, A., M. Kizaki, C. Kawamura, H. Matsushita, Y. Fukuchi, A. Umezawa, T.
Yamada, J. Hata, N. Hozumi, K. Yamato, et al. 2001. A novel differentia-
tion-inducing therapy for acute promyelocytic leukemia with a combination
of arsenic trioxide and GM-CSF. Leukemia. 15:1176–1184.
Negorev, D., and G.G. Maul. 2001. Cellular proteins localized at and interacting
within ND10/PML nuclear bodies/PODs suggest functions of a nuclear de-
pot. Oncogene. 20:7234–7242.
Regad, T., and M.K. Chelbi-Alix. 2001. Role and fate of PML nuclear bodies in re-
sponse to interferon and viral infections. Oncogene. 20:7274–7286.
Roix, J.J., P.G. McQueen, P.J. Munson, L.A. Parada, and T. Misteli. 2003. Spatial
proximity of translocation-prone gene loci in human lymphomas. Nat.
Genet. 34:287–291.
Ruggero, D., Z.G. Wang, and P.P. Pandolfi. 2000. The puzzling multiple lives of
PML and its role in the genesis of cancer. Bioessays. 22:827–835.
Seeler, J.S., and A. Dejean. 1999. The PML nuclear bodies: actors or extras? Curr.
Opin. Genet. Dev. 9:362–367.
Shiels, C., S.A. Islam, R. Vatcheva, P. Sasieni, M.J. Sternberg, P.S. Freemont, and
D. Sheer. 2001. PML bodies associate specifically with the MHC gene clus-
ter in interphase nuclei. J. Cell Sci. 114:3705–3716.
Shopland, L.S., M. Byron, J.L. Stein, J.B. Lian, G.S. Stein, and J.B. Lawrence.
2001. Replication-dependent histone gene expression is related to Cajal
body (CB) association but does not require sustained CB contact. Mol. Biol.
Cell. 12:565–576.
Smith, K.P., P.T. Moen, K.L. Wydner, J.R. Coleman, and J.B. Lawrence. 1999.
Processing of endogenous pre-mRNAs in association with SC-35 domains is
gene specific. J. Cell Biol. 144:617–629.
Tsukamoto, T., N. Hashiguchi, S.M. Janicki, T. Tumbar, A.S. Belmont, and D.L.
Spector. 2000. Visualization of gene activity in living cells. Nat. Cell Biol.
2:871–878.
Vallian, S., K.V. Chin, and K.S. Chang. 1998. The promyelocytic leukemia pro-
tein interacts with Sp1 and inhibits its transactivation of the epidermal
growth factor receptor promoter. Mol. Cell. Biol. 18:7147–7156.
van der Meijden, C.M., D.S. Lapointe, M.X. Luong, D. Peric-Hupkes, B. Cho, J.L.
Stein, A.J. van Wijnen, and G.S. Stein. 2002. Gene profiling of cell cycle pro-
gression through S-phase reveals sequential expression of genes required for
DNA replication and nucleosome assembly. Cancer Res. 62:3233–3243.
van Endert, P.M. 1999. Genes regulating MHC class I processing of antigen. Curr.
Opin. Immunol. 11:82–88.
Volpi, E.V., E. Chevret, T. Jones, R. Vatcheva, J. Williamson, S. Beck, R.D.
Campbell, M. Goldsworthy, S.H. Powis, J. Ragoussis, et al. 2000. Large-
scale chromatin organization of the major histocompatibility complex and
other regions of human chromosome 6 and its response to interferon in in-
terphase nuclei. J. Cell Sci. 113:1565–1576.
von Mikecz, A., S. Zhang, M. Montminy, E.M. Tan, and P. Hemmerich. 2000.
CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in
transcriptionally active domains in the nucleus. J. Cell Biol. 150:265–273.
Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A.
Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear lo-
calization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell.
76:345–356.
Williams, R.R., S. Broad, D. Sheer, and J. Ragoussis. 2002. Subchromosomal posi-
tioning of the epidermal differentiation complex (EDC) in keratinocyte and
lymphoblast interphase nuclei. Exp. Cell Res. 272:163–175.
Wu, W.S., Z.X. Xu, and K.S. Chang. 2002. The promyelocytic leukemia protein
represses A20-mediated transcription. J Biol Chem. 277: 31734–31739.
Zheng, P., Y. Guo, Q. Niu, D.E. Levy, J.A. Dyck, S. Lu, L.A. Sheiman, and Y.
Liu. 1998. Proto-oncogene PML controls genes devoted to MHC class I an-
tigen presentation. Nature. 396:373–376.